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Abstract
Aims: Trials of transcatheter renal artery denervation (RDN) have failed to show consistent antihyper-
tensive efficacy. Procedural factors and limitations of radiofrequency ablation can lead to incomplete 
denervation. The aim of the study was to show that non-contact microwave catheter ablation could produce 
deep circumferential perivascular heating while avoiding injury to the renal artery intima and media.
Methods and results: A novel microwave catheter was designed and tested in a renal artery model con-
sisting of layers of phantom materials embedded with a thermochromic liquid crystal sheet, colour range 
50-78°C. Ablations were performed at 140 W for 180 sec and 120 W for 210 sec, delivering 25,200 J with 
renal arterial flow at 0.5 L/min and 0.1 L/min. Transcatheter microwave ablations 100-160 W for 180 sec 
were then performed in the renal arteries of five sheep. In vitro, ablations at 140 W and 0.5 L/min flow pro-
duced circumferential lesions 5.9±0.2 mm deep and 19.2±1.5 mm long with subendothelial sparing depth 
of 1.0±0.1 mm. In vivo, transcatheter microwave ablation was feasible with no collateral visceral thermal 
injury. There was histological evidence of preferential outer media and adventitial ablation.
Conclusions: Transcatheter microwave ablation for RDN appears feasible and provides a heating pattern 
that may enable more complete denervation while sparing the renal arterial intima and media.
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Abbreviations
NBT nitroblue tetrazolium
RDN renal artery denervation
Introduction
Hypertension is a global health crisis, affecting one in three adults 
causing death and disability from cardiovascular disease1,2. In 
a Western population, up to one in eight patients fail to achieve 
adequate blood pressure control despite the use of three antihy-
pertensive agents and are termed to have resistant hypertension3. 
Renal efferent and afferent nerve hyperactivity in this patient 
group has been implicated as a major driver of hypertension, caus-
ing salt and fluid retention and increased vascular tone and heart 
rate4. Initially, in small clinical trials, transcatheter renal artery 
denervation (RDN) appeared safe and efficacious5. However, 
SYMPLICITY HTN-3, the largest randomised clinical trial 
for transcatheter RDN, failed to show blood pressure reduction 
against a sham control.
Radiofrequency energy has inherently limited depth of heating 
and ability to provide circumferential renal nerve ablation, which 
could contribute to incomplete denervation and inconsistent clini-
cal efficacy. Radiofrequency heating is ohmic and directly heats 
only a small region at the catheter tissue interface. The majority of 
lesion growth is driven by thermal conduction from this zone into 
the surrounding tissue6. Radiofrequency denervation systems must 
down-modulate power during ablation to avoid excessive catheter 
tissue interface heating and consequent vascular injury or throm-
bosis; this limits the average lesion depth to 2-4 mm7,8. Fixed per-
fused human cadaveric studies suggest that a 2 mm lesion depth 
could reach 30-50% of renal nerves and 4 mm lesion depth could 
reach 60-80%; yet, in order to reach at least 90% of renal nerves 
consistently, a depth of approximately 6 mm would be required9. 
As radiofrequency ablation causes transmural injury to the renal 
artery, a discontinuous spiral configuration of ablation lesion is 
necessary to avoid renal artery stenosis. The success of such a strat-
egy depends on a parallel course of renal nerves. Instead, renal 
nerves in humans probably form an arborising plexus as nerve bun-
dle counts differ between proximal, mid and distal renal artery seg-
ments9, giving rise to the possibility that such a set of focal lesions 
may be bypassed by the nerve network. Indeed, norepinephrine 
spillover measurements following radiofrequency RDN show 
inconsistent and incomplete levels of denervation10. Furthermore, 
recent animal studies of RDN using radiofrequency ablation have 
shown evidence of neuroregeneration at the site of focal ablation 
and full recovery of afferent and efferent renal nerve function by 
5.5 months, indicating that denervation is not sustained11,12.
Microwave energy has properties that are highly suited for RDN. 
Microwave heating is dielectric and not contact-dependent, mak-
ing it possible to heat deeper tissues directly while simultaneously 
avoiding high temperatures in the renal artery wall, which is cooled 
by adjacent blood flow13,14. We hypothesised that a microwave 
catheter centred in a renal artery could create a thermal lesion that 
is: (i) circumferential around the renal artery, and (ii) deeper than 
radiofrequency ablation with the potential to encompass the majority 
of renal nerves; while (iii) avoiding thermal injury to a subendothe-
lial zone thick enough to spare the renal artery intima and media. 
Using phantom renal artery models, we determined the heating pat-
tern produced by transcatheter microwave ablation and investigated 
the effects of renal artery flow and microwave energy delivery rate 
on thermal lesion dimensions. Subsequently, we performed trans-
catheter microwave ablation in a sheep model to demonstrate proce-
dural feasibility for RDN and provide preliminary observations on 
the immediate histological effects of microwave heating.
Methods
MICROWAVE ABLATION SYSTEM
An open irrigated 7 Fr microwave ablation catheter was designed 
and manually assembled. It consisted of a coaxial cable termi-
nating as a side-firing microwave radiator housed in an outer 
sheath with an inbuilt centring mechanism. Room temperature 
saline was infused between the outer sheath and the coaxial cable 
during ablation via a CoolFlow® pump (Biosense Webster, Inc., 
Diamond Bar, CA, USA) at 35 mL/min. The catheter radiating 
element length was optimised to provide good microwave cou-
pling to the renal artery model environment, with a standing wave 
ratio of 1.20, corresponding to a radiating efficiency of more than 
99%. During in vitro testing with ablation power up to 140 W and 
renal artery flow as low as 0.1 L/min, the temperature of the saline 
around the radiating element rose no more than approximately 
1°C irrespective of catheter irrigation, measured using Fluoroptic® 
thermometry with Luxtron probes (Model 3100; Luxtron Corp., 
now LumaSense Technologies, Inc., Santa Clara, CA, USA). 
Microwave power was supplied by a 2.45 GHz microwave gen-
erator (S250; Astex, now MKS Instruments, Inc., Wilmington, 
MA, USA). Power was measured using two Agilent V3500 power 
meters (Agilent Technologies, Santa Clara, CA, USA) connected 
to an eMeca 722–40–3.100 40 dB dual directional coupler (MECA 
Electronics Inc., Denville, NJ, USA).
LONGITUDINAL PHANTOM MODEL OF THE RENAL ARTERY
A longitudinal model of a 5 mm diameter renal artery was con-
structed using concentric layers of transparent phantom materials 
with similar microwave absorption, heating and heat conduction 
properties to their respective tissues. A 3 mm thick microwave 
muscle equivalent phantom layer consisting of 70% 0.9% saline 
and 30% glycerol mixed volume per volume as described previ-
ously15 solidified with 1% weight per volume gellan (Phytagel™; 
Sigma-Aldrich Corporation, St Louis, MO, USA) substituted 
the renal artery wall and inner nerve layers. A 10 mm thick 
poly(methyl-methacrylate) layer (permittivity=3.15, specific heat 
capacity=1.38 kJ/kg°C and thermal conductivity=0.19 W/m°C)16 
substituted the perinephric fat layer (fat permittivity=5.5, spe-
cific heat capacity=1.67 kJ/kg°C and thermal conductivity= 
0.18 W/m°C)17,18. Another layer of muscle equivalent phantom, 
peripheral to the perinephric fat, modelled potential water-rich 
nearby viscera. These materials were embedded with a custom 
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Transcatheter microwave renal artery denervation
thermochromic liquid crystal sheet that displayed a gradual tran-
sition in colours for temperatures between 50°C and 78°C. This 
technique of isothermal mapping has been validated previously 
and can determine phantom material temperatures with a stand-
ard error of 0.5°C19; 37°C 0.9% saline was perfused through the 
renal artery model with flow measured using a Dwyer RMB-82D-
SSV flow meter (Dwyer Instruments Pty Ltd, Unanderra, NSW, 
Australia) (Figure 1).
MICROWAVE ABLATION IN THE LONGITUDINAL PHANTOM 
MODEL, LESION MEASUREMENT AND STATISTICS
The microwave catheter was placed inside the modelled renal 
artery and centred using its own centring mechanism. Ablations 
were performed to deliver the same dose of energy (25,200 J of 
generator output) at 140 W for 180 sec and 120 W for 210 sec with 
Figure 1. Longitudinal phantom renal artery denervation model. 
A) Renal artery and adventitial nerve layer. B) Perinephric fat layer. 
C) Nearby viscera layer. D) Embedded sheet of thermochromic 
liquid crystal with colour range 50-78°C. E) 37°C 0.9% saline 
solution flowing though modelled renal artery lumen. F) Prototype 
microwave catheter placed in the renal artery model and centred 
using expandable splines.
renal artery flow at 0.5 L/min and 0.1 L/min. With each power 
and flow setting, ablations were performed four times with at least 
three minutes of cooling time in between ablations. Digital photo-
graphy of the thermochromic film was performed at baseline and 
then every 10 seconds to document lesion development. Thermal 
lesion boundaries were defined by the 53°C isotherm, which is the 
approximate temperature above which lethal hyperthermia occurs 
in muscle tissue20, and measured with in-house built software.
The maximal lesion depth and length as well as the depth of 
subendothelial sparing, defined as the minimal perpendicular dis-
tance from the luminal surface to the 53°C isotherm, were meas-
ured (Figure 2). GraphPad Prism 6 (GraphPad Software Inc., La 
Jolla, CA, USA) was used for statistical analysis. Averaged final 
lesion dimensions±SD were represented to the nearest 0.1 mm, 
and statistical comparisons between groups were made using 
unpaired t-tests and considered significant for p<0.05.
COMPARISON OF NON-CONTACT MICROWAVE AND 
RADIOFREQUENCY ABLATION TEMPERATURE DISTRIBUTION 
IN THE CROSS-SECTIONAL PHANTOM MODEL
A cross-sectional phantom renal artery model was used to compare 
the heating pattern between the Symplicity Flex™ denervation 
Figure 2. Thermal lesion produced by non-contact microwave 
ablation in the phantom model visualised on thermochromic liquid 
crystal sheet. A) Renal artery and adventitial nerve layer. 
B) Perinephric fat layer. C) Nearby viscera layer. M) Radiating 
element of the catheter. V) Renal artery lumen with flowing 37°C 
saline. Fluoroptic thermometry performed during catheter testing 
showed no more than 1°C rise of saline temperatures adjacent to the 
radiating element. d: lesion depth; l: lesion length; s: depth of 
subendothelial sparing
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system (Medtronic, Minneapolis, MN, USA) and the prototype 
microwave denervation system as previously described7. Briefly, 
it consisted of a block of transparent muscle equivalent phantom 
gel around a 5 mm diameter 0.9% normal saline filled renal artery 
with flow at 0.5 L/min and temperature 37°C. For radiofrequency 
ablation, a radiofrequency muscle equivalent phantom composed 
of 30% 0.9% saline and 70% distilled water mixed volume per 
volume was used, as described7, while for microwave ablations 
a microwave muscle equivalent phantom composed of 70% 0.9% 
saline and 30% glycerol mixed volume per volume was used15; 
both were solidified with 1% weight per volume gellan. The gels 
were embedded with discs of 50-78°C temperature range thermo-
chromic liquid crystal sheet to visualise lesion temperatures.
Radiofrequency ablation was performed at clinically recom-
mended settings of up to 8 W for 120 sec gated at 70°C catheter 
tip temperature. Microwave ablation was performed at 120 W for 
120 sec. Final ablation images were analysed with in-house built 
software, and GraphPad Prism 6 was used to plot the lesion tempera-
ture against perpendicular depth from the luminal surface (Figure 3).
TRANSCATHETER MICROWAVE ABLATION IN VIVO
The study was approved by the Western Sydney Local Health 
District Animal Ethics Committee. Five sheep underwent trans-
catheter microwave ablation under general anaesthesia. An 8.5 Fr 
Agilis™ sheath (St. Jude Medical, St. Paul, MN, USA) was intro-
duced via a femoral artery approach to engage the renal arteries 
and deliver the microwave ablation catheter under fluoroscopy 
(Artis zee; Siemens, Munich, Germany). One to two ablations 
were performed per renal artery at 100-160 W for 180 sec. Renal 
angiography was performed following ablations and the percent-
age of acute renal artery narrowing estimated visually by a cardio-
logist (P. Qian). The sheep were euthanised immediately post 
procedure to inspect for the extent of visible injury to adjacent 
organs and to remove the renal artery and kidneys for assessment.
Microwave ablation Radiofrequency ablation
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Figure 3. In vitro comparison of lesion temperature distribution between microwave and radiofrequency ablation. Microwave ablation 
performed at 120 W for 120 sec provided a more uniform thermal distribution and lower peak lesion temperature than the Symplicity Flex 
denervation system at standard clinical settings (up to 8 W, catheter temperature 70°C, for 120 sec). Tissue temperatures near vessel lumen 
were minimal with microwave ablation as compared with radiofrequency ablation which exceeded 78°C (outside the colour range of the 
thermochromic liquid crystal material).
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Transcatheter microwave renal artery denervation
For the first sheep, the perinephric fat around the renal artery 
was stripped before staining with nitroblue tetrazolium (NBT) for 
72 hrs at 4°C. The perinephric fat was kept intact around the renal 
arteries in subsequent sheep. Specimens were fixed with 10% neu-
tral buffered formalin before paraffin embedding and staining with 
haematoxylin and eosin.
QUANTITATIVE ANALYSIS OF NBT STAINING
Relative reductions in blue colour intensity after NBT staining 
inferring ablated tissue were confirmed using quantitative col-
orimetry. Digital photographs of the NBT-stained excised renal 
arteries were imported into in-house software, which was devel-
oped using MATLAB (R2014b; The MathWorks, Inc., Natick, 
MA, USA). Automated quantitative assessment of microwave 
lesions was performed using the following approach: (1) selection 
of the region of interest; (2) regional extraction of red, blue and 
green colour composites, with dimensionless values from 0 to 1, 
for each longitudinal segment (averaged latitudinally); (3) regional 
subtraction of green and red intensity values from twice the blue 
intensity value to obtain a relative blue intensity; (4) taking the 
difference between the relative blue intensities at each longitudinal 
position along the renal arteries with that of an unablated section 
to obtain a differential blue intensity. Regions with a differential 
blue intensity <0 thus indicated less NBT staining compared with 
the referenced normal tissue.
Results
MICROWAVE ABLATION HEATING PATTERN AND LESION 
DIMENSIONS IN THE PHANTOM RENAL ARTERY MODELS
Microwave ablation produced circumferential thermal lesions in 
the phantom models. Lesion growth occurred in the perivascular 
region and expanded towards the perinephric fat layer and the arte-
rial lumen. Ablations at 140 W compared with 120 W at 0.5 L/min 
renal artery flow yielded significantly longer (19.2±1.5 mm vs. 
15.2±2.2 mm, p<0.001) and deeper (5.9±0.2 mm vs. 5.5±0.3 mm, 
p<0.03) lesions with less subendothelial sparing (1.0±0.1 mm vs. 
1.2±0.1 mm, p<0.001). At 180 sec into ablation with 0.5 L/min 
renal artery flow, the greater cumulative microwave dose delivered 
at 140 W compared with 120 W produced deeper (4.8±0.3 mm 
vs. 4.0±0.4 mm, p<0.0002) and longer lesions (19.2±1.5 mm 
vs. 14.9±2.3 mm, p<0.0006) with less subendothelial sparing 
(1.0±0.1 mm vs. 1.2±0.1 mm, p<0.002). At the reduced arte-
rial flow rate of 0.1 L/min, lesion length and depth were similar 
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Figure 4. Microwave thermal lesion dimensions. The average depth 
from the lumen of the vessel that is spared from lethal heating is 
shown at each time point with 95% confidence intervals (A). The 
average lesion depth is shown at each time point during ablation 
with 95% confidence intervals (B).
Table 1. Final lesion characteristics at varying power and renal artery flow.
Lesion depth (±SD)
Subendothelial sparing 
depth (±SD)
Lesion length (±SD)
Mean peak lesion 
temperature (±SD)
120 W for 210 sec at 0.5 L/min 5.5±0.3 mm 1.2±0.1 mm 15.2±2.2 mm 67.0±0.7°C
120 W for 210 sec at 0.1 L/min 5.6±0.3 mm 1.1±0.1 mm 16.9±1.8 mm 66.8±0.6°C
140 W for 180 sec at 0.5 L/min 5.9±0.2 mm 1.0±0.1 mm 19.2±1.5 mm 67.5±1.0°C
140 W for 180 sec at 0.1 L/min 5.8±0.3 mm 0.8±0.1 mm 18.2±2.0 mm 68.1±0.6°C
between 120 W and 140 W ablations but subendothelial spar-
ing was reduced at the higher ablation power (0.8±0.1 mm vs. 
1.1±0.1 mm, p<0.0002) (Table 1, Figure 4). The mean peak lesion 
temperatures were similar in high and low renal artery flow condi-
tions at 120 W and 140 W and did not exceed approximately 68°C 
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(Table 1). No heating peripheral to the 10 mm thick perinephric 
fat layer was observed in any of the ablations.
MICROWAVE AND RADIOFREQUENCY ABLATION 
TEMPERATURE DISTRIBUTIONS
Microwave ablations produced a zone of subendothelial sparing with 
temperatures peaking in the perivascular region. Radiofrequency 
ablation produced peak heating at the catheter tissue interface, which 
was beyond the 78°C upper limit of the TLC, that dropped away 
rapidly with depth. Microwave heating produced a more homo-
genous temperature distribution with lower peak lesion temperature 
than radiofrequency ablation. The depth of lethal hyperthermia was 
notably greater with microwave as compared with radiofrequency 
ablation at the tested ablation settings (Figure 3).
TRANSCATHETER MICROWAVE ABLATION IN SHEEP
The investigational microwave transcatheter system was deployed 
and ablation performed in eight of ten targeted renal arteries. Of the 
two renal arteries that could not be treated, one could not be found 
using the Agilis sheath and the other was not ablated due to techni-
cal failure of the irrigation pump; these have not been included in 
the analysis. Nine ablations were performed: three 160 W ablations, 
three 140 W ablations, two 120 W ablations and a 100 W ablation. 
All of these ablations were delivered to the middle portion of the 
renal artery except for an ablation at 140 W, which was performed 
in the distal renal artery at a trifurcation close to the renal hilum. 
Following microwave ablation, renal artery spasm was routinely 
observed causing <50% renal artery narrowing in eight of nine abla-
tions (Figure 5). One ablation produced an eccentric 80% narrowing 
after 160 W was applied in a tortuous renal artery, but there was no 
histological evidence of transmural arterial injury at this site.
No gross acute injuries to nearby viscera were observed with 
any ablations. Histological assessment showed a notable lack of 
architectural disruption. Renal arterial ablation injury was seen in 
only four of nine ablations. Eccentric catheter position accounted 
for two of these, which demonstrated a region of linear transmu-
ral injury. No circumferential transmural injury was observed in 
any of the specimens. In each case where ablation to the renal 
arterial wall was seen, there were regions where a predominantly 
outer media and adventitial ablation had taken place with spar-
ing of more inner layers of the vessel wall (Figure 6). When the 
renal artery was directly stained with NBT, circumferential abla-
tion to the adventitial aspect of the renal arteries could be bet-
ter appreciated. Again, regions of preferential adventitial ablation 
with sparing of the luminal aspect of the artery were seen (Figure 
5). No immediate histological changes could be appreciated in the 
perivascular region.
Discussion
In these studies we have demonstrated that microwave energy can 
be used to perform a circumferential perivascular ablation with 
controllable lesion depth and subendothelial sparing. The potential 
to deliver deeper and more complete ablation of the renal nerves 
while avoiding significant renal arterial injury provides important 
advantages over radiofrequency ablation systems. This may enable 
a microwave ablation system to achieve more consistent and dur-
able denervation efficacy.
In the phantom renal artery model, non-contact transcatheter 
microwave ablation was capable of forming circumferential lesions 
5.9 mm deep at the tested ablation settings. This depth is superior 
to the 3.4-3.8 mm achieved using EnligHTN™ (St. Jude Medical) 
and Symplicity denervation systems when tested in a similar in 
vitro preparation and sufficient to encompass approximately 90% 
of renal nerves circumferentially if reproduced in vivo7,9. Also, 
lesion lengths in vitro were up to 19.2 mm from a single ablation, 
posing a substantial gap over which neuroregenerative responses 
must bridge to reinnervate. Subendothelial sparing varied between 
approximately 0.8 and 1.2 mm, sufficient to spare the renal arterial 
intima and media which is approximately 0.5 mm21.
Perivascular thermal lesion growth was governed by the bal-
ance between microwave heating and luminal cooling from arte-
rial flow acting in opposition. Higher cumulative microwave 
energy dose increased lesion depth, and a lower rate of energy 
delivery (power) enabled increased subendothelial sparing. In the 
case of low renal artery flow, the same microwave energy load 
can be given over a longer duration at lower power to achieve 
a similar lesion depth but with significantly more subendothe-
lial sparing (Table 1, Figure 4). The near absence of catheter 
tip heating with microwave ablation (only 1°C) makes it pos-
sible to use much higher powers to achieve larger volume ther-
mal lesions compared with radiofrequency ablation, where high 
catheter-tissue interface temperatures limit ablation power and 
lesion depth (Figure 3).
In vivo study demonstrated the feasibility and acute tolerabil-
ity of delivering a microwave transcatheter device transarterially 
and performing an ablation. The procedure appeared safe with no 
collateral thermal injury observed to adjacent organs despite abla-
tions up to 160 W, as predicted in vitro. Cooling from renal artery 
flow was sufficient in vivo during these ablations to protect against 
significant arterial injury despite high ablation power. Regions of 
ablation in the renal artery wall involving the outer media and 
adventitia with subendothelial sparing could be appreciated histo-
logically and on viability staining with NBT (Figure 5, Figure 6). 
Where transmural arterial ablation had occurred due to eccentric 
catheter position, they were linear and parallel with the artery and 
not expected to result in renal artery stenosis. Renal nerve injury 
could not be appreciated at this early time point immediately fol-
lowing ablation. The subtle histological changes and absence of 
coagulative necrosis or tissue desiccation was consistent with 
a low temperature thermal injury, as seen in vitro. Histological 
assessment of ablation lesions at days or weeks post procedure is 
required to demarcate the full extent of irreversible thermal tis-
sue injury.
Novel denervation technologies capable of circumferential 
ablation such as the ultrasound-based Paradise® System (ReCor 
Medical, Palo Alto, CA, USA) and the injection-based Peregrine 
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System™ (Ablative Solutions, Kalamazoo, MI, USA) have shown 
capacity to produce renal denervation in preclinical studies and 
are the subject of ongoing clinical trials. It remains to be dem-
onstrated that these technologies are superior to radiofrequency 
ablation in producing durable denervation. Microwave ablation 
has the theoretical advantage over these systems in terms of pen-
etration through areas of vascular calcification. Given the differ-
ent mechanism by which these novel modalities produce tissue 
injury, comparison of lesion formation capacity and effectiveness 
of subsequent neuro-regenerative responses requires long-term 
in vivo studies.
Study limitations
Microwave thermal lesion dimensions in vitro may not be indica-
tive of the ablation lesions in vivo at the same ablation settings. 
However, given the potential renal artery intima and media spar-
ing with non-contact microwave ablation in vitro and in vivo, we 
posit that sufficiently high energy ablations could allow deep cir-
cumferential lesions to be delivered in vivo. We did not determine 
whether the microwave ablations delivered in vivo led to renal 
denervation. Given the high microwave ablation powers used, 
it was necessary to establish that the procedure could be safely per-
formed in order to plan longer-term dose-finding in vivo studies.
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Figure 5. Gross histological changes after intravascular non-contact microwave ablation in sheep renal artery. Renal angiography of the right 
(A) and left (B) renal arteries after ablations at the indicated power (black arrows) for 180 sec. Nitroblue tetrazolium treatment revealed 
circumferential adventitial thermal injury at the site of each ablation (C). In the 140 W and 120 W ablations, inspection of the vessel lumen 
showed viable tissue anteriorly indicating a predominantly adventitial ablation in this region. Posteriorly, there was ablation to both the 
luminal and the adventitial aspect, indicating a linear transmural lesion due to eccentric catheter position. The 100 W ablation produced 
a predominantly adventitial ablation (D). Colorimetric analysis confirmed adventitial ablation (E).
e1914
EuroIntervention 2
0
17;1
2
:e
19
0
7-e
1915
Conclusions
We have provided a proof of principle that microwave transcatheter 
ablation from within the renal artery can create deep circumferential 
perivascular heating while avoiding circumferential transmural arte-
rial ablation. This heating pattern may enable more consistent and 
complete renal nerve ablation to be performed without significant 
arterial injury. We have also demonstrated the feasibility of perform-
ing transcatheter non-contact microwave RDN in vivo.
Impact on daily practice
The use of radiofrequency energy for RDN has inherent bio-
physical limitations that impact on the effectiveness and dura-
bility of therapy; these may be overcome by novel methods 
and energy sources. We have demonstrated the potential for 
microwave energy to be used for RDN and the value of using 
an in vitro phantom model for assaying and optimising novel 
denervation technology. Without careful preclinical evalua-
tion, optimisation and comparison of denervation technologies 
to improve the potential consistency and durability of therapy, 
future clinical trials of RDN risk futility due to ineffective 
denervation.
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